Sort by
Refine Your Search
-
of compounds that inhibit a critical protein target that will lead to drugs for currently untreated cancer types. It employs cutting-edge structure based drug design and property-based optimisation approaches
-
advanced patient-derived tumour models and use them to test promising therapeutic targets that exploit vulnerabilities caused by loss of the SMARCB1 gene. This role offers an excellent opportunity to further
Searches related to bayesian target
Enter an email to receive alerts for bayesian-target positions